Yaz, Similar Pills Tied To Higher Blood Clot Risks

Law360, New York (April 22, 2011, 5:30 PM EDT) -- Two medical studies published Thursday found that women taking drospirenone-containing birth control pills such as Bayer HealthCare Pharmaceuticals Inc.'s Yasmin and Yaz could be at higher risk of blood clots than those taking oral contraceptives with a different progestin hormone.

The studies in the British Medical Journal, which involved U.S. and U.K. women who used oral contraceptives containing drospirenone or levonorgestrel, come amid a flood of personal injury and wrongful death lawsuits against Bayer over the safety of its popular birth control pills and whether company...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.